Research ExplorerPublicationsRecommendations for vaccination in multiple myeloma: a conse...

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

Standard

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network. / Ludwig, Heinz; Boccadoro, Mario; Moreau, Philippe; San-Miguel, Jesus; Cavo, Michele; Pawlyn, Charlotte; Zweegman, Sonja; Facon, Thierry; Driessen, Christoph; Hajek, Roman; Dimopoulos, Melitios A; Gay, Francesca; Avet-Loiseau, Hervé; Terpos, Evangelos; Zojer, Niklas; Mohty, Mohamad; Mateos, Maria-Victoria; Einsele, Hermann; Delforge, Michel; Caers, Jo; Weisel, Katja; Jackson, Graham; Garderet, Laurent; Engelhardt, Monika; van de Donk, Niels; Leleu, Xavier; Goldschmidt, Hartmut; Beksac, Meral; Nijhof, Inger; Abildgaard, Niels; Bringhen, Sara; Sonneveld, Pieter.

In: LEUKEMIA, Vol. 35, No. 1, 01.2021, p. 31-44.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Ludwig, H, Boccadoro, M, Moreau, P, San-Miguel, J, Cavo, M, Pawlyn, C, Zweegman, S, Facon, T, Driessen, C, Hajek, R, Dimopoulos, MA, Gay, F, Avet-Loiseau, H, Terpos, E, Zojer, N, Mohty, M, Mateos, M-V, Einsele, H, Delforge, M, Caers, J, Weisel, K, Jackson, G, Garderet, L, Engelhardt, M, van de Donk, N, Leleu, X, Goldschmidt, H, Beksac, M, Nijhof, I, Abildgaard, N, Bringhen, S & Sonneveld, P 2021, 'Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network', LEUKEMIA, vol. 35, no. 1, pp. 31-44. https://doi.org/10.1038/s41375-020-01016-0

APA

Ludwig, H., Boccadoro, M., Moreau, P., San-Miguel, J., Cavo, M., Pawlyn, C., Zweegman, S., Facon, T., Driessen, C., Hajek, R., Dimopoulos, M. A., Gay, F., Avet-Loiseau, H., Terpos, E., Zojer, N., Mohty, M., Mateos, M-V., Einsele, H., Delforge, M., ... Sonneveld, P. (2021). Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network. LEUKEMIA, 35(1), 31-44. https://doi.org/10.1038/s41375-020-01016-0

Vancouver

Ludwig H, Boccadoro M, Moreau P, San-Miguel J, Cavo M, Pawlyn C et al. Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network. LEUKEMIA. 2021 Jan;35(1):31-44. https://doi.org/10.1038/s41375-020-01016-0

Bibtex

@article{53535f2fd5ac4859b7c577bcc750a58d,
title = "Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network",
abstract = "Vaccination is one of the most successful medical interventions that has saved the life of millions of people. Vaccination is particularly important in patients with multiple myeloma, who have an increased risk of infections due to the disease-inherent immune suppression, and because of the immune suppressive effects of therapy. Hence, all appropriate measures should be exploited, to elicit an effective immune response to common pathogens like influenza, pneumococci, varicella zoster virus, and to those bacteria and viruses (haemophilus influenzae, meningococci, and hepatitis) that frequently may pose a significant risk to patients with multiple myeloma. Patients after autologous, and specifically after allogeneic transplantation have severely reduced antibody titers, and therefore require a broader spectrum of vaccinations. Response to vaccination in myeloma often is less vigorous than in the general population, mandating either measurement of the postvaccination antibody titers and/or repeating the vaccination. Here, we compile the existing data on vaccination in multiple myeloma and provide recommendations for clinical practice.",
author = "Heinz Ludwig and Mario Boccadoro and Philippe Moreau and Jesus San-Miguel and Michele Cavo and Charlotte Pawlyn and Sonja Zweegman and Thierry Facon and Christoph Driessen and Roman Hajek and Dimopoulos, {Melitios A} and Francesca Gay and Herv{\'e} Avet-Loiseau and Evangelos Terpos and Niklas Zojer and Mohamad Mohty and Maria-Victoria Mateos and Hermann Einsele and Michel Delforge and Jo Caers and Katja Weisel and Graham Jackson and Laurent Garderet and Monika Engelhardt and {van de Donk}, Niels and Xavier Leleu and Hartmut Goldschmidt and Meral Beksac and Inger Nijhof and Niels Abildgaard and Sara Bringhen and Pieter Sonneveld",
year = "2021",
month = jan,
doi = "10.1038/s41375-020-01016-0",
language = "English",
volume = "35",
pages = "31--44",
journal = "LEUKEMIA",
issn = "0887-6924",
publisher = "NATURE PUBLISHING GROUP",
number = "1",

}

RIS

TY - JOUR

T1 - Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

AU - Ludwig, Heinz

AU - Boccadoro, Mario

AU - Moreau, Philippe

AU - San-Miguel, Jesus

AU - Cavo, Michele

AU - Pawlyn, Charlotte

AU - Zweegman, Sonja

AU - Facon, Thierry

AU - Driessen, Christoph

AU - Hajek, Roman

AU - Dimopoulos, Melitios A

AU - Gay, Francesca

AU - Avet-Loiseau, Hervé

AU - Terpos, Evangelos

AU - Zojer, Niklas

AU - Mohty, Mohamad

AU - Mateos, Maria-Victoria

AU - Einsele, Hermann

AU - Delforge, Michel

AU - Caers, Jo

AU - Weisel, Katja

AU - Jackson, Graham

AU - Garderet, Laurent

AU - Engelhardt, Monika

AU - van de Donk, Niels

AU - Leleu, Xavier

AU - Goldschmidt, Hartmut

AU - Beksac, Meral

AU - Nijhof, Inger

AU - Abildgaard, Niels

AU - Bringhen, Sara

AU - Sonneveld, Pieter

PY - 2021/1

Y1 - 2021/1

N2 - Vaccination is one of the most successful medical interventions that has saved the life of millions of people. Vaccination is particularly important in patients with multiple myeloma, who have an increased risk of infections due to the disease-inherent immune suppression, and because of the immune suppressive effects of therapy. Hence, all appropriate measures should be exploited, to elicit an effective immune response to common pathogens like influenza, pneumococci, varicella zoster virus, and to those bacteria and viruses (haemophilus influenzae, meningococci, and hepatitis) that frequently may pose a significant risk to patients with multiple myeloma. Patients after autologous, and specifically after allogeneic transplantation have severely reduced antibody titers, and therefore require a broader spectrum of vaccinations. Response to vaccination in myeloma often is less vigorous than in the general population, mandating either measurement of the postvaccination antibody titers and/or repeating the vaccination. Here, we compile the existing data on vaccination in multiple myeloma and provide recommendations for clinical practice.

AB - Vaccination is one of the most successful medical interventions that has saved the life of millions of people. Vaccination is particularly important in patients with multiple myeloma, who have an increased risk of infections due to the disease-inherent immune suppression, and because of the immune suppressive effects of therapy. Hence, all appropriate measures should be exploited, to elicit an effective immune response to common pathogens like influenza, pneumococci, varicella zoster virus, and to those bacteria and viruses (haemophilus influenzae, meningococci, and hepatitis) that frequently may pose a significant risk to patients with multiple myeloma. Patients after autologous, and specifically after allogeneic transplantation have severely reduced antibody titers, and therefore require a broader spectrum of vaccinations. Response to vaccination in myeloma often is less vigorous than in the general population, mandating either measurement of the postvaccination antibody titers and/or repeating the vaccination. Here, we compile the existing data on vaccination in multiple myeloma and provide recommendations for clinical practice.

U2 - 10.1038/s41375-020-01016-0

DO - 10.1038/s41375-020-01016-0

M3 - SCORING: Review article

C2 - 32814840

VL - 35

SP - 31

EP - 44

JO - LEUKEMIA

JF - LEUKEMIA

SN - 0887-6924

IS - 1

ER -